[go: up one dir, main page]

DE60115863D1 - Beta 1, 2-xylosyltransferase gen aus arabidopsis - Google Patents

Beta 1, 2-xylosyltransferase gen aus arabidopsis

Info

Publication number
DE60115863D1
DE60115863D1 DE60115863T DE60115863T DE60115863D1 DE 60115863 D1 DE60115863 D1 DE 60115863D1 DE 60115863 T DE60115863 T DE 60115863T DE 60115863 T DE60115863 T DE 60115863T DE 60115863 D1 DE60115863 D1 DE 60115863D1
Authority
DE
Germany
Prior art keywords
arabidopsis
beta
less
glycoprotein
human protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60115863T
Other languages
English (en)
Other versions
DE60115863T2 (de
DE60115863T3 (de
Inventor
Josef Gloessl
Richard Strasser
Jan Mucha
Lukas Mach
Friedrich Altmann
B Wilson
Herta Steinkellner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3672559&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60115863(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of DE60115863D1 publication Critical patent/DE60115863D1/de
Publication of DE60115863T2 publication Critical patent/DE60115863T2/de
Application granted granted Critical
Publication of DE60115863T3 publication Critical patent/DE60115863T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1077—Pentosyltransferases (2.4.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/02—Pentosyltransferases (2.4.2)
    • C12Y204/02038—Glycoprotein 2-beta-D-xylosyltransferase (2.4.2.38)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01024—Alpha-mannosidase (3.2.1.24)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/0105—Alpha-N-acetylglucosaminidase (3.2.1.50)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01052—Beta-N-acetylhexosaminidase (3.2.1.52)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
DE60115863.6T 2000-03-03 2001-03-02 Beta 1, 2-xylosyltransferase gen aus arabidopsis Expired - Lifetime DE60115863T3 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AT0035500A AT409381B (de) 2000-03-03 2000-03-03 Xylosyltransferase-gen
AT3552000 2000-03-03
PCT/EP2001/002352 WO2001064901A1 (en) 2000-03-03 2001-03-02 Beta 1, 2-xylosyltransferase-gene from arabidopsis
EP01919367.1A EP1263968B2 (de) 2000-03-03 2001-03-02 Beta 1, 2-xylosyltransferase gen aus arabidopsis

Publications (3)

Publication Number Publication Date
DE60115863D1 true DE60115863D1 (de) 2006-01-19
DE60115863T2 DE60115863T2 (de) 2006-08-10
DE60115863T3 DE60115863T3 (de) 2015-01-22

Family

ID=3672559

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60115863.6T Expired - Lifetime DE60115863T3 (de) 2000-03-03 2001-03-02 Beta 1, 2-xylosyltransferase gen aus arabidopsis

Country Status (12)

Country Link
US (3) US7205137B2 (de)
EP (2) EP1263968B2 (de)
JP (2) JP5279976B2 (de)
KR (5) KR100861437B1 (de)
AT (2) AT409381B (de)
AU (1) AU781010B2 (de)
CA (1) CA2402015C (de)
DE (1) DE60115863T3 (de)
DK (2) DK1621633T3 (de)
ES (2) ES2460672T3 (de)
PT (1) PT1621633E (de)
WO (1) WO2001064901A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01005778A (es) 1998-12-09 2003-07-21 Dow Chemical Co Un metodo para fabricar glicoproteinas que tienen glicosilacion de tipo humano.
PT1772518E (pt) 1999-10-26 2010-10-28 Stichting Dienst Landbouwkundi Glicosilação do tipo mamífero em plantas
ZA200306406B (en) 2001-01-19 2004-09-06 Dow Chemical Co Method for secretory production of glycoprotein having human-type sugar chain using plant cell.
KR101060361B1 (ko) 2002-03-19 2011-08-29 스티칭 디엔스트 랜드보위쿤디그 온데조에크 식물에서 글리칸 프로세싱의 최적화
NZ534881A (en) 2002-03-19 2006-09-29 Plant Res Internat B Mammalian GnTIII expression in plants
AR042145A1 (es) 2002-11-27 2005-06-08 Dow Agrociences Llc Produccion de inmunoglobulinas en plantas con una fucocilacion reducida
EP1510584B1 (de) 2003-08-11 2009-03-18 Greenovation Biotech GmbH Promoter Sequenzen aus Moos und dessen Verwendung
NZ598048A (en) 2006-01-17 2013-05-31 Synthon Biopharmaceuticals Bv Compositions and methods for humanization and optimization of n-glycans in plants
US20090060921A1 (en) * 2006-01-17 2009-03-05 Biolex Therapeutics, Inc. Glycan-optimized anti-cd20 antibodies
US20100287657A1 (en) * 2006-03-23 2010-11-11 Bayer Bioscience N.V. Novel Nucleotide Sequences Encoding Nicotiana Beta-1,2-Xylosyltransferase
KR101460953B1 (ko) 2007-04-17 2014-11-13 스티칭 디엔스트 랜드보위쿤디그 온데조에크 비-포유동물 글리코실트랜스퍼라제의 발현에 의한 식물에서의 포유동물형 글리코실화
MX2009013325A (es) * 2007-06-07 2010-05-20 Ca Minister Agriculture & Food Transfeccion y transduccion de plantas con base en nano acarreadores.
EP2789686A1 (de) 2013-04-11 2014-10-15 Greenovation Biotech GmbH Expression von phosphorylierten Glycoproteinen in Pflanzen
JP6934666B2 (ja) * 2018-01-18 2021-09-15 国立研究開発法人産業技術総合研究所 植物細胞においてキシロース修飾タンパク質を製造する方法、コアオリゴ糖修飾タンパク質を製造する方法、及びプロテオグリカンを製造する方法
EP3871687A1 (de) 2020-02-27 2021-09-01 eleva GmbH Enzymersatztherapie zur behandlung der pompe-krankheit

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001507563A (ja) * 1995-11-23 2001-06-12 キャンサー リサーチ キャンペーン テクノロジー リミテッド Ｂｒｃａ２癌感受性遺伝子の同定及び配列決定に関する材料及び方法並びにそれらの使用
AU1808699A (en) * 1997-12-08 1999-06-28 Board Of Trustees Of The University Of Arkansas, The Purified beta1,2-xylosyltransferase and uses thereof
DE19754622A1 (de) † 1997-12-09 1999-06-10 Antje Von Dr Schaewen Pflanzliche GntI-Sequenzen und Verwendung derselben zur Gewinnung von Pflanzen mit verminderter oder fehlender N-Acetylglucosaminyltransferase I (GnTI)-Aktivität
JP2003520012A (ja) * 1997-12-19 2003-07-02 ファルマシア・アンド・アップジョン・カンパニー ヒトＳｅｌ−１０ポリペプチドおよびそれをコードするポリヌクレオチド
US6207811B1 (en) * 1998-03-18 2001-03-27 Karl Tryggvason Nephrin gene and protein
CA2339409A1 (en) * 1998-08-11 2000-02-24 Darwin Discovery Ltd. Identification of the gene causing the mouse scurfy phenotype and its human ortholog
EP1033405A3 (de) * 1999-02-25 2001-08-01 Ceres Incorporated DNS-fragmente mit bestimmter Sequenz und die dadurch kodierte Polypeptide
AU1573601A (en) * 1999-10-21 2001-04-30 Monsanto Company Post-translational modification of recombinant proteins produced in plants

Also Published As

Publication number Publication date
EP1621633A2 (de) 2006-02-01
AU4649501A (en) 2001-09-12
ES2252208T3 (es) 2006-05-16
US20040121325A1 (en) 2004-06-24
DK1621633T3 (da) 2014-05-19
ES2460672T3 (es) 2014-05-14
AU781010B2 (en) 2005-04-28
US20070186311A1 (en) 2007-08-09
JP2013116113A (ja) 2013-06-13
CA2402015A1 (en) 2001-09-07
ATE312931T1 (de) 2005-12-15
AT409381B (de) 2002-07-25
DE60115863T2 (de) 2006-08-10
KR20070058018A (ko) 2007-06-07
PT1621633E (pt) 2014-07-18
KR20090101981A (ko) 2009-09-29
KR20100119005A (ko) 2010-11-08
KR101185123B1 (ko) 2012-09-21
KR20030030987A (ko) 2003-04-18
JP5279976B2 (ja) 2013-09-04
CA2402015C (en) 2012-07-17
EP1263968B2 (de) 2014-09-10
EP1263968B1 (de) 2005-12-14
ATA3552000A (de) 2001-12-15
EP1621633B1 (de) 2014-04-16
EP1621633A3 (de) 2006-02-08
US7205137B2 (en) 2007-04-17
KR20080077296A (ko) 2008-08-21
DE60115863T3 (de) 2015-01-22
KR100859919B1 (ko) 2008-09-23
ES2252208T5 (es) 2014-11-04
DK1263968T4 (da) 2014-11-03
JP2004500096A (ja) 2004-01-08
US20120331578A1 (en) 2012-12-27
EP1263968A1 (de) 2002-12-11
WO2001064901A1 (en) 2001-09-07
DK1263968T3 (da) 2006-05-01
KR100861437B1 (ko) 2008-10-02

Similar Documents

Publication Publication Date Title
ATE312931T1 (de) Beta 1, 2-xylosyltransferase gen aus arabidopsis
ATE291626T1 (de) Regulierung von pflanzenwachstum
NO20011861L (no) Interferon-<beta> fusjonsproteiner samt anvendelse derav
IL193758A0 (en) Genetically engineered duckweed
NO20100324L (no) Fremgangsmate for trinnvis festing av polyetylenglykol (PEG) andeler i serie til et polypeptid
DE60137587D1 (de) Antimikrobielle peptide und deren verwendung
ES2124532T3 (es) Sistema vector-huesped utilizable en terapia genica.
WO2003078614A3 (en) Gntiii (udp-n-acethylglucosamine:beta-d mannoside beta (1,4)-n-acethylglucosaminy ltransferase iii) expression in plants
WO1999046366A8 (en) Uses for humane non-autologous mesenchymal stem cells
BR9507385A (pt) Gene rps2 e usos do mesmo
DE60135393D1 (de) Allelische Variante des Interferon-ähnlichen Proteins Zcyto21
DK0614980T3 (da) Trans-dominante TAT-varianter fra humant immundeficiens-virus
AR029644A1 (es) Proteina aislada, polinucleotido aislado, celula huesped transgenica, metodo para controlar una plaga que no es de mamiferos, cultivo biologicamente puro
WO2004005467A3 (en) Expression of human interferon in transgenic chloroplasts
DK0728208T3 (da) Tomat-xyloglucan-endo-transglycosylase
NZ296562A (en) Recombinant peptides and secretory mehods for their preparation
DE60329115D1 (de) Tumorantigenprotein und dessen verwendung
AR024430A1 (es) Proteinas insecticidas y combinaciones sinergicas de las mismas
DE60042922D1 (de) Virale expressionsvektoren für pflanzen
ATE452903T1 (de) Modifizierte peptide und deren verwendung zur behandlung von autoimmunkrankheiten
BR9807616A (pt) Aminopeptidase derivada de bacillus licheniformis e processo para preparação de proteìnas tipo natural
SG170757A1 (en) Polypeptide having esterase activity and recombinant esterase and use thereof
EP1295943A4 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
GB2441941A (en) An isolated recombinant vaccinia virus complement control protein (HRVCP) polypeptide
WO2003016490A3 (en) Rna silencing suppression

Legal Events

Date Code Title Description
8363 Opposition against the patent